KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Minority Interest (2020 - 2025)

Historic Minority Interest for AbbVie (ABBV) over the last 6 years, with Q3 2025 value amounting to $43.0 million.

  • AbbVie's Minority Interest rose 1025.64% to $43.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 1025.64%. This contributed to the annual value of $39.0 million for FY2024, which is 540.54% up from last year.
  • Latest data reveals that AbbVie reported Minority Interest of $43.0 million as of Q3 2025, which was up 1025.64% from $45.0 million recorded in Q2 2025.
  • AbbVie's 5-year Minority Interest high stood at $45.0 million for Q2 2025, and its period low was $23.0 million during Q1 2021.
  • Moreover, its 5-year median value for Minority Interest was $35.0 million (2022), whereas its average is $34.7 million.
  • Its Minority Interest has fluctuated over the past 5 years, first soared by 4210.53% in 2021, then tumbled by 857.14% in 2023.
  • Quarter analysis of 5 years shows AbbVie's Minority Interest stood at $28.0 million in 2021, then rose by 17.86% to $33.0 million in 2022, then increased by 12.12% to $37.0 million in 2023, then rose by 5.41% to $39.0 million in 2024, then rose by 10.26% to $43.0 million in 2025.
  • Its last three reported values are $43.0 million in Q3 2025, $45.0 million for Q2 2025, and $42.0 million during Q1 2025.